Colleen F. Reitan

Insider Reports History

Location
Cambridge, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Colleen F. Reitan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Colleen F. Reitan:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 775 $372,759 $480.98 09 Sep 2025 Direct
MYRIAD GENETICS INC Director Common Stock 92,329 $372,085 $4.03 05 Jun 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 0 09 Sep 2025 Direct

Insider Reports Filed by Colleen F. Reitan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALNY ALNYLAM PHARMACEUTICALS, INC. 09 Sep 2025 18 -$6,605,030 4 Director 11 Sep 2025, 16:05
MYGN MYRIAD GENETICS INC 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:04
MYGN MYRIAD GENETICS INC 03 Sep 2024 1 -$1,285,851 4 Director 04 Sep 2024, 19:38
ALNY ALNYLAM PHARMACEUTICALS, INC. 29 Aug 2024 5 +$1,980 4 Director 12 May 2025, 16:05
MYGN MYRIAD GENETICS INC 06 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:54
ALNY ALNYLAM PHARMACEUTICALS, INC. 16 May 2024 1 $0 4 Director 20 May 2024, 16:06
MYGN MYRIAD GENETICS INC 01 Jun 2023 1 $0 4 Director 02 Jun 2023, 18:11
ALNY ALNYLAM PHARMACEUTICALS, INC. 18 May 2023 1 $0 4 Director 19 May 2023, 16:05
MYGN MYRIAD GENETICS INC 02 Jun 2022 1 $0 4 Director 03 Jun 2022, 17:25
ALNY ALNYLAM PHARMACEUTICALS, INC. 18 May 2022 1 $0 4 Director 20 May 2022, 16:07
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Jul 2021 1 $0 4 Director 19 Jul 2021, 16:22
MYGN MYRIAD GENETICS INC 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 19:43